3rdPartyFeeds

Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know

In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $8.88, marking a +1.02% move from the previous day. Read More...
Regal Beloit (RBC) delivered earnings and revenue surprises of 1.42% and -2.98%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Aurora Cannabis Inc. (ACB) closed at $8.88 in the latest trading session, marking a +1.02% move from the prior day. This change outpaced the S&P 500’s 0.45% loss on the day. At the same time, the Dow lost 0.25%, and the tech-heavy Nasdaq lost 0.5%.

Coming into today, shares of the company had lost 1.79% in the past month. In that same time, the Medical sector lost 2.4%, while the S&P 500 gained 2.62%.

Wall Street will be looking for positivity from ACB as it approaches its next earnings report date. The company is expected to report EPS of -$0.03, up 25% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $55.12 million, up 332.65% from the prior-year quarter.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$0.18 per share and revenue of $206.61 million, which would represent changes of -250% and +376.36%, respectively, from the prior year.

Investors should also note any recent changes to analyst estimates for ACB. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.96% lower. ACB is currently sporting a Zacks Rank of #3 (Hold).

The Medical – Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 171, which puts it in the bottom 34% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
&nbsp;
Aurora Cannabis Inc. (ACB) : Free Stock Analysis Report
&nbsp;
To read this article on Zacks.com click here.” data-reactid=”32″>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Aurora Cannabis Inc. (ACB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Read More

Add Comment

Click here to post a comment